Sickle Cell Gene Therapy Uptake May Lag, But Still Shock State Medicaid Budgets

 
• By Sarah Karlin-Smith
  
3d render of exponential red arrow pointing upwards
State Medicaid programs will face exponential new costs for sickle cell patients with new gene therapies • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet